3H-ouabain accumulation and Na+-K+-ATPase activity in relation to therapeutic, toxic, and lethal doses of ouabain in dogs.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000818:Animals; D001665:Binding Sites; D002467:Cell Nucleus / Q000378:metabolism; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D008931:Mitochondria, Muscle / Q000378:metabolism; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000201:enzymology / Q000648:ultrastructure; D010042:Ouabain / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D013997:Time Factors
D010042:Ouabain; D000251:Adenosine Triphosphatases